Chemiluminescence
(CL) with stable and glowing light emission is
vital for the accurate detection of biomarkers. Moreover, the catalyst
plays an important role in CL systems. Herein, the trimetallic AuPtCo
nanopolyhedrons with peroxidase- and catalase-like catalytic activities
are readily synthesized via a one-step reduction method. After reaction
with the substrate ABEI and oxidant H2O2, the
AuPtCo nanozyme can catalyze the CL emission in a flash type. Interestingly,
it has been found that the biofunctionalization of the AuPtCo surface
can endow the catalytic interface with a slow-diffusion effect, thereby
prolonging the emission of glow-type CL. On this basis, two biofunctionalized
AuPtCo nanocomposites, named as AuPtCo@Cys and AuPtCo@Ab, are prepared,
achieving sensitive and selective detection of H2O2 and lipoprotein-associated phospholipase A2 (Lp-PLA2), respectively. Further, the proposed glow-type CL assays
are successfully applied for the determination of H2O2 and Lp-PLA2 in female vaginal discharge and human
serum samples, respectively, which exhibit good correlation with the
clinical results. Overall, the trimetallic AuPtCo nanozyme-based glow-type
CL analysis has demonstrated as a powerful and robust tool for biomarker
analysis, which holds great promise in clinical applications.